Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 8495 entries
Sorted by: Best Match Show Resources per page
EUFOREA treatment algorithm for allergic rhinitis.

Rhinology

Hellings PW, Scadding G, Bachert C, Bjermer L, Canonica GW, Cardell LO, Carney AS, Constantinidis J, Deneyer L, Diamant Z, Durham S, Gevaert P, Harvey R, Hopkins C, Kjeldsen A, Klimek L, Lund VJ, Price D, Rimmer J, Ryan D, Roberts G, Sahlstrand-Johnson P, Salmi S, Samji M, Scadding G, Smith P, Steinsvik A, Wagenmann M, Seys S, Wahn U, Fokkens WJ.
PMID: 32991658
Rhinology. 2020 Dec 01;58(6):618-622. doi: 10.4193/Rhin20.246.

No abstract available.

Cite
Hellings PW, Scadding G, Bachert C, et al. EUFOREA treatment algorithm for allergic rhinitis. Rhinology. 2020;58(6):618-622doi: 10.4193/Rhin20.246.
Hellings, P. W., Scadding, G., Bachert, C., Bjermer, L., Canonica, G. W., Cardell, L. O., Carney, A. S., Constantinidis, J., Deneyer, L., Diamant, Z., Durham, S., Gevaert, P., Harvey, R., Hopkins, C., Kjeldsen, A., Klimek, L., Lund, V. J., Price, D., Rimmer, J., Ryan, D., Roberts, G., Sahlstrand-Johnson, P., Salmi, S., Samji, M., Scadding, G., Smith, P., Steinsvik, A., Wagenmann, M., Seys, S., Wahn, U., & Fokkens, W. J. (2020). EUFOREA treatment algorithm for allergic rhinitis. Rhinology, 58(6), 618-622. https://doi.org/10.4193/Rhin20.246
Hellings, P W, et al. "EUFOREA treatment algorithm for allergic rhinitis." Rhinology vol. 58,6 (2020): 618-622. doi: https://doi.org/10.4193/Rhin20.246
Hellings PW, Scadding G, Bachert C, Bjermer L, Canonica GW, Cardell LO, Carney AS, Constantinidis J, Deneyer L, Diamant Z, Durham S, Gevaert P, Harvey R, Hopkins C, Kjeldsen A, Klimek L, Lund VJ, Price D, Rimmer J, Ryan D, Roberts G, Sahlstrand-Johnson P, Salmi S, Samji M, Scadding G, Smith P, Steinsvik A, Wagenmann M, Seys S, Wahn U, Fokkens WJ. EUFOREA treatment algorithm for allergic rhinitis. Rhinology. 2020 Dec 01;58(6):618-622. doi: 10.4193/Rhin20.246. PMID: 32991658.
Copy Download .nbib Format: NLM
Management of asthma in adults in primary care.

Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia

Ban A, Omar A, Chong LY, Lockman H, Ida Zaliza ZA, Ali I, Jaya M, Leong SW, Mazapuspavina MY, Yusof M, Zim M, Nor Azila MI, Jamal SM, Yoon CK, Malek Abdol Hamid ZI.
PMID: 30800229
Malays Fam Physician. 2018 Dec 31;13(3):20-26. eCollection 2018.

Asthma is a chronic inflammatory disease of the airway which is often misdiagnosed and undertreated. Early diagnosis and vigilant asthma control are crucial to preventing permanent airway damage, improving quality of life and reducing healthcare burdens. The key approaches...

Cite
Ban A, Omar A, Chong LY, et al. Management of asthma in adults in primary care. Malays Fam Physician. 2018;13(3):20-26
Ban, A., Omar, A., Chong, L. Y., Lockman, H., Ida Zaliza, Z. A., Ali, I., Jaya, M., Leong, S. W., Mazapuspavina, M. Y., Yusof, M., Zim, M., Nor Azila, M. I., Jamal, S. M., Yoon, C. K., & Malek Abdol Hamid, Z. I. (2018). Management of asthma in adults in primary care. Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia, 13(3), 20-26.
Ban, Ayl, et al. "Management of asthma in adults in primary care." Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia vol. 13,3 (2018): 20-26.
Ban A, Omar A, Chong LY, Lockman H, Ida Zaliza ZA, Ali I, Jaya M, Leong SW, Mazapuspavina MY, Yusof M, Zim M, Nor Azila MI, Jamal SM, Yoon CK, Malek Abdol Hamid ZI. Management of asthma in adults in primary care. Malays Fam Physician. 2018 Dec 31;13(3):20-26. eCollection 2018. PMID: 30800229; PMCID: PMC6382081.
Copy Download .nbib Format: NLM
Immuno-PET Imaging to Assess Target Engagement: Experience from .

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Menke-van der Houven van Oordt CW, McGeoch A, Bergstrom M, McSherry I, Smith DA, Cleveland M, Al-Azzam W, Chen L, Verheul H, Hoekstra OS, Vugts DJ, Freedman I, Huisman M, Matheny C, van Dongen G, Zhang S.
PMID: 30733323
J Nucl Med. 2019 Jul;60(7):902-909. doi: 10.2967/jnumed.118.214726. Epub 2019 Feb 07.

PET imaging with radiolabeled drugs provides information on tumor uptake and dose-dependent target interaction to support selection of an optimal dose for future efficacy testing. In this immuno-PET study of the anti-human epidermal growth factor receptor (HER3) mAb GSK2849330,...

Cite
Menke-van der Houven van Oordt CW, McGeoch A, Bergstrom M, et al. Immuno-PET Imaging to Assess Target Engagement: Experience from . J Nucl Med. 2019;60(7):902-909doi: 10.2967/jnumed.118.214726.
Menke-van der Houven van Oordt, C. W., McGeoch, A., Bergstrom, M., McSherry, I., Smith, D. A., Cleveland, M., Al-Azzam, W., Chen, L., Verheul, H., Hoekstra, O. S., Vugts, D. J., Freedman, I., Huisman, M., Matheny, C., van Dongen, G., & Zhang, S. (2019). Immuno-PET Imaging to Assess Target Engagement: Experience from . Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 60(7), 902-909. https://doi.org/10.2967/jnumed.118.214726
Menke-van der Houven van Oordt, C Willemien, et al. "Immuno-PET Imaging to Assess Target Engagement: Experience from ." Journal of nuclear medicine : official publication, Society of Nuclear Medicine vol. 60,7 (2019): 902-909. doi: https://doi.org/10.2967/jnumed.118.214726
Menke-van der Houven van Oordt CW, McGeoch A, Bergstrom M, McSherry I, Smith DA, Cleveland M, Al-Azzam W, Chen L, Verheul H, Hoekstra OS, Vugts DJ, Freedman I, Huisman M, Matheny C, van Dongen G, Zhang S. Immuno-PET Imaging to Assess Target Engagement: Experience from . J Nucl Med. 2019 Jul;60(7):902-909. doi: 10.2967/jnumed.118.214726. Epub 2019 Feb 07. PMID: 30733323; PMCID: PMC6604691.
Copy Download .nbib Format: NLM
Immune Check Point Inhibitors in Cancer Therapy: Beware of "Friendly Fire" Effect.

Research & reviews. Journal of hospital and clinical pharmacy

Kommalapati A, Sikder S, Tella SH.
PMID: 29291253
Res Rev J Hosp Clin Pharm. 2017 Jul;3(2):5-6. Epub 2017 Jun 08.

No abstract available.

Cite
Kommalapati A, Sikder S, Tella SH. Immune Check Point Inhibitors in Cancer Therapy: Beware of "Friendly Fire" Effect. Res Rev J Hosp Clin Pharm. 2017;3(2):5-6
Kommalapati, A., Sikder, S., & Tella, S. H. (2017). Immune Check Point Inhibitors in Cancer Therapy: Beware of "Friendly Fire" Effect. Research & reviews. Journal of hospital and clinical pharmacy, 3(2), 5-6.
Kommalapati, Anuhya, et al. "Immune Check Point Inhibitors in Cancer Therapy: Beware of "Friendly Fire" Effect." Research & reviews. Journal of hospital and clinical pharmacy vol. 3,2 (2017): 5-6.
Kommalapati A, Sikder S, Tella SH. Immune Check Point Inhibitors in Cancer Therapy: Beware of "Friendly Fire" Effect. Res Rev J Hosp Clin Pharm. 2017 Jul;3(2):5-6. Epub 2017 Jun 08. PMID: 29291253; PMCID: PMC5744671.
Copy Download .nbib Format: NLM
Impact of Norepinephrine Shortage on Outcomes in Patients with Septic Shock.

Research & reviews. Journal of hospital and clinical pharmacy

Nappi JM, Sieg A, Hassig TB, Wahlquist AE.
PMID: 28804796
Res Rev J Hosp Clin Pharm. 2016 May;2(2):87-91. Epub 2016 May 12.

PURPOSE: With the previous norepinephrine shortage, alternative agents were required to treat patients with septic shock. This retrospective study evaluated whether the shortage of norepinephrine had an adverse effect on patients admitted to the intensive care unit with a...

Cite
Nappi JM, Sieg A, Hassig TB, et al. Impact of Norepinephrine Shortage on Outcomes in Patients with Septic Shock. Res Rev J Hosp Clin Pharm. 2016;2(2):87-91
Nappi, J. M., Sieg, A., Hassig, T. B., & Wahlquist, A. E. (2016). Impact of Norepinephrine Shortage on Outcomes in Patients with Septic Shock. Research & reviews. Journal of hospital and clinical pharmacy, 2(2), 87-91.
Nappi, Jean M, et al. "Impact of Norepinephrine Shortage on Outcomes in Patients with Septic Shock." Research & reviews. Journal of hospital and clinical pharmacy vol. 2,2 (2016): 87-91.
Nappi JM, Sieg A, Hassig TB, Wahlquist AE. Impact of Norepinephrine Shortage on Outcomes in Patients with Septic Shock. Res Rev J Hosp Clin Pharm. 2016 May;2(2):87-91. Epub 2016 May 12. PMID: 28804796; PMCID: PMC5553972.
Copy Download .nbib Format: NLM
A phase 2 study of ofatumumab (Arzerra.

Leukemia & lymphoma

Chen CI, Paul H, Le LW, Wei EN, Snitzler S, Wang T, Levina O, Kakar S, Lau A, Queau M, Johnston JB, Smith DA, Trudel S.
PMID: 29916761
Leuk Lymphoma. 2019 Jan;60(1):92-100. doi: 10.1080/10428194.2018.1468892. Epub 2018 Jun 19.

AKT plays a centralized role in tumor proliferation and survival and is aberrantly activated in chronic lymphocytic leukemia (CLL). In this phase 2 trial, 30 relapsed/refractory CLL patients were treated with combination afuresertib, a novel oral AKT inhibitor, and...

Cite
Chen CI, Paul H, Le LW, et al. A phase 2 study of ofatumumab (Arzerra. Leuk Lymphoma. 2018;60(1):92-100doi: 10.1080/10428194.2018.1468892.
Chen, C. I., Paul, H., Le, L. W., Wei, E. N., Snitzler, S., Wang, T., Levina, O., Kakar, S., Lau, A., Queau, M., Johnston, J. B., Smith, D. A., & Trudel, S. (2019). A phase 2 study of ofatumumab (Arzerra. Leukemia & lymphoma, 60(1), 92-100. https://doi.org/10.1080/10428194.2018.1468892
Chen, Christine I, et al. "A phase 2 study of ofatumumab (Arzerra." Leukemia & lymphoma vol. 60,1 (2019): 92-100. doi: https://doi.org/10.1080/10428194.2018.1468892
Chen CI, Paul H, Le LW, Wei EN, Snitzler S, Wang T, Levina O, Kakar S, Lau A, Queau M, Johnston JB, Smith DA, Trudel S. A phase 2 study of ofatumumab (Arzerra. Leuk Lymphoma. 2019 Jan;60(1):92-100. doi: 10.1080/10428194.2018.1468892. Epub 2018 Jun 19. PMID: 29916761.
Copy Download .nbib Format: NLM
The ICQ Asthma Algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management.

Allergy

Papi A, Jesenak M, Alfano F, G Peroni D, Baraldi F, Diamant Z.
PMID: 34614223
Allergy. 2021 Oct 06; doi: 10.1111/all.15131. Epub 2021 Oct 06.

No abstract available.

Cite
Papi A, Jesenak M, Alfano F, et al. The ICQ Asthma Algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management. Allergy. 2021;doi: 10.1111/all.15131.
Papi, A., Jesenak, M., Alfano, F., G Peroni, D., Baraldi, F., & Diamant, Z. (2021). The ICQ Asthma Algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management. Allergy, . https://doi.org/10.1111/all.15131
Papi, Alberto, et al. "The ICQ Asthma Algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management." Allergy vol. (2021). doi: https://doi.org/10.1111/all.15131
Papi A, Jesenak M, Alfano F, G Peroni D, Baraldi F, Diamant Z. The ICQ Asthma Algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management. Allergy. 2021 Oct 06; doi: 10.1111/all.15131. Epub 2021 Oct 06. PMID: 34614223.
Copy Download .nbib Format: NLM
A Practical First Step Using Needs Assessment and a Survey Approach to Implementing a Clinical Pharmacogenomics Consult Service.

Journal of the American College of Clinical Pharmacy : JACCP

Zakinova A, Long-Boyle JR, French D, Croci R, Wilson L, Phillips KA, Kroetz DL, Shin J, Tamraz B.
PMID: 32391517
J Am Coll Clin Pharm. 2019 Jun;2(3):214-221. doi: 10.1002/jac5.1062. Epub 2018 Nov 22.

INTRODUCTION: Genetic-guided selection of non-oncologic medications is not commonly practiced in general, and at University of California, San Francisco (UCSF) Health, specifically. Understanding the unique position of clinicians with respect to clinical pharmacogenetics (PG) at a specific institution or...

Cite
Zakinova A, Long-Boyle JR, French D, et al. A Practical First Step Using Needs Assessment and a Survey Approach to Implementing a Clinical Pharmacogenomics Consult Service. J Am Coll Clin Pharm. 2018;2(3):214-221doi: 10.1002/jac5.1062.
Zakinova, A., Long-Boyle, J. R., French, D., Croci, R., Wilson, L., Phillips, K. A., Kroetz, D. L., Shin, J., & Tamraz, B. (2019). A Practical First Step Using Needs Assessment and a Survey Approach to Implementing a Clinical Pharmacogenomics Consult Service. Journal of the American College of Clinical Pharmacy : JACCP, 2(3), 214-221. https://doi.org/10.1002/jac5.1062
Zakinova, Angela, et al. "A Practical First Step Using Needs Assessment and a Survey Approach to Implementing a Clinical Pharmacogenomics Consult Service." Journal of the American College of Clinical Pharmacy : JACCP vol. 2,3 (2019): 214-221. doi: https://doi.org/10.1002/jac5.1062
Zakinova A, Long-Boyle JR, French D, Croci R, Wilson L, Phillips KA, Kroetz DL, Shin J, Tamraz B. A Practical First Step Using Needs Assessment and a Survey Approach to Implementing a Clinical Pharmacogenomics Consult Service. J Am Coll Clin Pharm. 2019 Jun;2(3):214-221. doi: 10.1002/jac5.1062. Epub 2018 Nov 22. PMID: 32391517; PMCID: PMC7207007.
Copy Download .nbib Format: NLM
Rethinking the Drug Distribution and Medication Management Model: How a New York City Hospital Pharmacy Department Responded to COVID-19.

Journal of the American College of Clinical Pharmacy : JACCP

Dzierba AL, Pedone T, Patel MK, Ciolek A, Mehta M, Berger K, Ramos LG, Patel VD, Littlefield A, Chuich T, May HB, Muir J, Verkerk BS, Poon T, Der-Nigoghossian C, Nikolos P, Gunther M, Shah J, Witenko CJ.
PMID: 32838224
J Am Coll Clin Pharm. 2020 Aug 12; doi: 10.1002/jac5.1316. Epub 2020 Aug 12.

Beginning in March 2020, New York City began the fight against coronavirus disease 2019. Health care workers were faced with a disease that led to significant morbidity and mortality with no proven therapies. As hospitals became inundated with patients...

Cite
Dzierba AL, Pedone T, Patel MK, et al. Rethinking the Drug Distribution and Medication Management Model: How a New York City Hospital Pharmacy Department Responded to COVID-19. J Am Coll Clin Pharm. 2020;doi: 10.1002/jac5.1316.
Dzierba, A. L., Pedone, T., Patel, M. K., Ciolek, A., Mehta, M., Berger, K., Ramos, L. G., Patel, V. D., Littlefield, A., Chuich, T., May, H. B., Muir, J., Verkerk, B. S., Poon, T., Der-Nigoghossian, C., Nikolos, P., Gunther, M., Shah, J., & Witenko, C. J. (2020). Rethinking the Drug Distribution and Medication Management Model: How a New York City Hospital Pharmacy Department Responded to COVID-19. Journal of the American College of Clinical Pharmacy : JACCP, . https://doi.org/10.1002/jac5.1316
Dzierba, Amy L, et al. "Rethinking the Drug Distribution and Medication Management Model: How a New York City Hospital Pharmacy Department Responded to COVID-19." Journal of the American College of Clinical Pharmacy : JACCP vol. (2020). doi: https://doi.org/10.1002/jac5.1316
Dzierba AL, Pedone T, Patel MK, Ciolek A, Mehta M, Berger K, Ramos LG, Patel VD, Littlefield A, Chuich T, May HB, Muir J, Verkerk BS, Poon T, Der-Nigoghossian C, Nikolos P, Gunther M, Shah J, Witenko CJ. Rethinking the Drug Distribution and Medication Management Model: How a New York City Hospital Pharmacy Department Responded to COVID-19. J Am Coll Clin Pharm. 2020 Aug 12; doi: 10.1002/jac5.1316. Epub 2020 Aug 12. PMID: 32838224; PMCID: PMC7436296.
Copy Download .nbib Format: NLM
Implementation of warfarin to direct oral anticoagulant conversion initiative in pharmacist-run anticoagulation clinics during COVID-19 pandemic.

Journal of the American College of Clinical Pharmacy : JACCP

Kish K, Lekic S.
PMID: 34226885
J Am Coll Clin Pharm. 2021 Jun 08; doi: 10.1002/jac5.1470. Epub 2021 Jun 08.

Due to community transmission of coronavirus disease 2019 (COVID-19), social distancing and stay-at-home orders were implemented statewide in an effort to limit the spread of disease. This posed unique challenges for patients on medications requiring close and continued monitoring...

Cite
Kish K, Lekic S. Implementation of warfarin to direct oral anticoagulant conversion initiative in pharmacist-run anticoagulation clinics during COVID-19 pandemic. J Am Coll Clin Pharm. 2021;doi: 10.1002/jac5.1470.
Kish, K., & Lekic, S. (2021). Implementation of warfarin to direct oral anticoagulant conversion initiative in pharmacist-run anticoagulation clinics during COVID-19 pandemic. Journal of the American College of Clinical Pharmacy : JACCP, . https://doi.org/10.1002/jac5.1470
Kish, Katie, and Lekic, Sanela. "Implementation of warfarin to direct oral anticoagulant conversion initiative in pharmacist-run anticoagulation clinics during COVID-19 pandemic." Journal of the American College of Clinical Pharmacy : JACCP vol. (2021). doi: https://doi.org/10.1002/jac5.1470
Kish K, Lekic S. Implementation of warfarin to direct oral anticoagulant conversion initiative in pharmacist-run anticoagulation clinics during COVID-19 pandemic. J Am Coll Clin Pharm. 2021 Jun 08; doi: 10.1002/jac5.1470. Epub 2021 Jun 08. PMID: 34226885; PMCID: PMC8242517.
Copy Download .nbib Format: NLM
How-To Guide for Overcoming Barriers of Research and Scholarship Training in Pharm.D. and Pharmacy Residency Programs.

Journal of the American College of Clinical Pharmacy : JACCP

Morbitzer KA, McLaughlin JE, Devanathan AS, Ozawa S, McClurg MR, Carpenter DM, Lee CR.
PMID: 34355135
J Am Coll Clin Pharm. 2021 Jun;4(6):743-753. Epub 2021 Mar 13.

Accrediting bodies for Doctor of Pharmacy (Pharm.D.) and postgraduate residency training programs recognize the importance of research and scholarship training. However, specific guidance on how research and scholarship fundamentals should be delivered to trainees have not been provided. As...

Cite
Morbitzer KA, McLaughlin JE, Devanathan AS, et al. How-To Guide for Overcoming Barriers of Research and Scholarship Training in Pharm.D. and Pharmacy Residency Programs. J Am Coll Clin Pharm. 2021;4(6):743-753
Morbitzer, K. A., McLaughlin, J. E., Devanathan, A. S., Ozawa, S., McClurg, M. R., Carpenter, D. M., & Lee, C. R. (2021). How-To Guide for Overcoming Barriers of Research and Scholarship Training in Pharm.D. and Pharmacy Residency Programs. Journal of the American College of Clinical Pharmacy : JACCP, 4(6), 743-753.
Morbitzer, Kathryn A, et al. "How-To Guide for Overcoming Barriers of Research and Scholarship Training in Pharm.D. and Pharmacy Residency Programs." Journal of the American College of Clinical Pharmacy : JACCP vol. 4,6 (2021): 743-753.
Morbitzer KA, McLaughlin JE, Devanathan AS, Ozawa S, McClurg MR, Carpenter DM, Lee CR. How-To Guide for Overcoming Barriers of Research and Scholarship Training in Pharm.D. and Pharmacy Residency Programs. J Am Coll Clin Pharm. 2021 Jun;4(6):743-753. Epub 2021 Mar 13. PMID: 34355135; PMCID: PMC8330697.
Copy Download .nbib Format: NLM
Pharmacists and opioid use disorder care during COVID-19: Call for action.

Journal of the American College of Clinical Pharmacy : JACCP

Mohammad I, Berri D, Tutag Lehr V.
PMID: 34909605
J Am Coll Clin Pharm. 2021 Nov 08; doi: 10.1002/jac5.1556. Epub 2021 Nov 08.

Opioid use disorder (OUD) is a chronic relapsing condition characterized by problematic opioid use causing significant impairment in daily life. Medication for opioid use disorder using buprenorphine, methadone, and naltrexone with behavioral therapy reduces illicit opioid use and risk...

Cite
Mohammad I, Berri D, Tutag Lehr V. Pharmacists and opioid use disorder care during COVID-19: Call for action. J Am Coll Clin Pharm. 2021;doi: 10.1002/jac5.1556.
Mohammad, I., Berri, D., & Tutag Lehr, V. (2021). Pharmacists and opioid use disorder care during COVID-19: Call for action. Journal of the American College of Clinical Pharmacy : JACCP, . https://doi.org/10.1002/jac5.1556
Mohammad, Insaf, et al. "Pharmacists and opioid use disorder care during COVID-19: Call for action." Journal of the American College of Clinical Pharmacy : JACCP vol. (2021). doi: https://doi.org/10.1002/jac5.1556
Mohammad I, Berri D, Tutag Lehr V. Pharmacists and opioid use disorder care during COVID-19: Call for action. J Am Coll Clin Pharm. 2021 Nov 08; doi: 10.1002/jac5.1556. Epub 2021 Nov 08. PMID: 34909605; PMCID: PMC8661525.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 8495 entries